持续性坐骨动脉动脉瘤的内血管治疗,由下肢动脉栓塞复杂化
Wenfei Guan1,2,3, Peng Jiang1,2,3, Yongpan Cui1,2,3
1Department of Vascular Surgery, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
概括
持续性坐骨动脉 (PSA) 是一种罕见的血管疾病. 这项研究强调了同时治疗PSA动脉瘤和相关栓塞的重要性,有利于微创内血管修复.
科学领域:
- 血管外科 血管外科
- 遗传性血管形 遗传性血管形
- 血管内干预 血管内干预
背景情况:
- 持续性坐骨动脉 (PSA) 是一种罕见的先天性血管异常.
- 大多数PSA病例无症状,但症状表现包括神经疼痛和缺血性疼痛.
- 动脉瘤破裂是PSA的危及生命的并发症.
研究的目的:
- 探索PSA的临床特征和治疗策略.
- 为了呈现PSA与远端栓塞的病例.
- 强调PSA动脉瘤和血栓栓塞的同时治疗的重要性.
主要方法:
- 一个患有PSA和远端栓塞的病人的病例报告.
- 对PSA的临床特征和治疗选择的审查.
- 一个分阶段的,混合的内血管方法的描述.
主要成果:
- 血管内修复是PSA的首选,最少的侵入性策略.
- 同时治疗动脉瘤和栓塞对于症状性PSA至关重要.
- 一个分阶段的混合内血管方法证明了有效性.
结论:
- 及时检测和干预对于管理PSA至关重要.
- 对动脉瘤和栓塞的联合干预可以防止复发.
- 姿势修改可能是缓慢动脉瘤进展的辅助.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
601
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
601
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
467
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
467
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
508
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
508
Arteries of Lower Limbs
4.5K
The external iliac artery transitions out of the body cavity, entering the femoral region of the lower leg, and is renamed the femoral artery at the point where it traverses the body wall. This artery is responsible for the distribution of blood to the thigh's deep muscles and the skin's ventral and lateral regions, achieved through several minor branches and the lateral deep femoral artery, which also spawns a lateral circumflex artery. The knee area receives blood from the genicular...
4.5K
Arteries and Arterioles
6.6K
Arteries, the vasculature responsible for transporting blood from the heart, possess robust walls capable of enduring the elevated pressures exerted by the heartbeat. Arteries near the heart are especially thick-walled and enriched with elastic fibers across their three tunics, classifying them as elastic or conducting arteries. These arteries, usually with a diameter exceeding 10 mm, are characterized by their ability to dilate in response to the blood pumped from the heart's ventricles...
6.6K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
619
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
619


